Oxford Talks
Toggle navigation
Help
Login
Dr Barry Davis
AstraZeneca
Events this person is speaking at:
Monday 2 November 2015
11:00
-
Development of AZD5363, an inhibitor of AKT with activity in tumours containing mutations in the P13K-AKT pathway
Dr Barry Davis
( AstraZeneca)
Department of Oncology